Indeterminate pulmonary nodules: Risk for having or for developing lung cancer?

Chest

Volumn 146, Issue 6, 2014, Pages 1173-1178

  Massion, Pierre P ^a,b   Walker, Ronald C ^a,b,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; BIOLOGICAL MARKER;

CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; HUMAN; INDETERMINATE PULMONARY NODULE; LUNG CANCER; LUNG NODULE; MEDICAL HISTORY; MORBIDITY; PATIENT IDENTIFICATION; REVIEW; RISK ASSESSMENT; TUMOR VOLUME; CANCER DIAGNOSIS; CANCER SCREENING; HEALTH CARE COST; MEDICAL PRACTICE; PRECURSOR; PRIORITY JOURNAL; COMPLICATION; EARLY DIAGNOSIS; LUNG NEOPLASMS; MULTIPLE PULMONARY NODULES; RISK FACTOR;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MULTIPLE PULMONARY NODULES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938068169     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0364     Document Type: Review

References (56)

1. Aberle DR, Adams AM, BergCD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;5:395-409.
2. Boiselle PM, Chiles C, Patz E, Tammemagi M, Wood DE. Expert opinion: United States preventive services task force recommendation on screening for lung cancer. J Thorac Imaging 2014;4:197.
3. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;5:311-20.
4. Pinsky P, Nath H, Gierada D, Sonavane S, Szabo E. Short- and longterm lung cancer risk associated with non-calcified nodules observed on low-dose CT. Cancer Prev Res 2014;7:1179-85.
5. Nagler R, Savulescu D, Krayzler E, Leschiner S, Veenman L, Gavish M. Cigarette smoke decreases salivary 18 kDa translocator protein binding affinity - in association with oxidative stress. Curr Med Chem 2010;23:2539-46.
6. Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, et al. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer 2014;20:3401-9.
7. Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen HJ, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;8:848-54.
8. Henschke CI, Yip R, Yankelevitz DF, Smith JP. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Inter Med 2013;4:246-52.
9. Yip R, Henschke CI, Yankelevitz DF, Smith JP. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. Radiology 2014;273:591-6.
10. Ost DE, Gould MK. Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med 2012;4:363-72.
11. Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Land-reneau RJ, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008;9:956-61.
12. Rampinelli C, De Fiori E, Raimondi S, Veronesi G, Bellomi M. In vivo repeatability of automated volume calculations of small pulmonary nodules with CT. AJR Am J Roentgenol 2009;6:1657-61.
13. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;9173:99-105.
14. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;5:1053-7.
15. Henschke CI, Yankelevitz DF, Libby DM, McCauley D, Pasmantier M, Altorki NK, et al. Early lung cancer action project: annual screening using single-slice helical CT. Ann N Y Acad Sci 2001; 952:124-34.
16. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):94S-107S.
17. Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: ACCP evidence-based clinical practice guidelines. Chest 2013;143 (5 Suppl):e93S-120S.
18. Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;2: 240-65.
19. Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;2:177-84.
20. Gould MK, Fletcher J, Iannettoni MD, Lynch WR, Midthun DE, Naidich DP, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):108S-30S.
21. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2007;2:395-400.
22. Tammemagi MC, Freedman MT, Pinsky PF, Oken MM, Hu P, Riley TL, et al. Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol 2009;6: 710-21.
23. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;23:2221-9.
24. Xu DM, van der Zaag-Loonen HJ, Oudkerk M, Wang Y, Vliegenthart R, Scholten ET, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 2009;1:264-72.
25. Gavrielides MA, Kinnard LM, Myers KJ, Petrick N. Noncalcified lung nodules: volumetric assessment with thoracic CT. Radiology 2009; 1:26-37.
26. Wang Y, de Bock GH, van Klaveren RJ, van Ooyen P, Tukker W, Zhao Y, et al. Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variability. Eur Radiol 2010;5:1180-7.
27. Wood DE. Lung cancer screening: the last10 years. JNatl Compr Canc Netw 2012;11:1323-5.
28. Oda S, Awai K, Murao K, Ozawa A, Yanaga Y, Kawanaka K, et al. Computer-aided volumetry of pulmonary nodules exhibiting ground-glass opacity at MDCT. AJR Am J Roentgenol 2010;2:398-406.
29. Gould MK. Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery. Thorax 2011;4:277-9.
30. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;1:251-6.
31. Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology 1993;2:415-22.
32. Gould MK, Ananth L, Barnett PG. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007;2:383-8.
33. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Int Med 1997;8: 849-55.
34. Pecot CV, Li M, Zhang XJ, Rajanbabu R, Calitri C, Bungum A, et al. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev 2012; 5:786-92.
35. Isbell JM, Deppen S, Putnam JB Jr, Nesbitt JC, Lambright ES, Dawes A, et al. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg 2011;1:227-33.
36. McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;10:910-9.
37. Maisonneuve P, Bagnardi V, Bellomi M, Spaggiari L, Pelosi G, Rampinelli C, et al. Lung cancer risk prediction to select smokers for screening CT-a model based on the Italian COSMOS trial. Cancer Prev Res 2011;11:1778-89.
38. Keith RL, Miller YE. Lung cancer chemoprevention: current status and future prospects. Nature reviews. Clin Oncol 2013;6:334-43.
39. Szabo E, Mao JT, Lam S, Reid ME, Keith RL. Chemoprevention of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e40S-60S.
40. Ishizumi T, McWilliams A, MacAulay C, Gazdar A, Lam S. Natural history of bronchial preinvasive lesions. Cancer Metastasis Rev 2010;1:5-14.
41. Hirsch FR, Prindiville SA, Miller YE, Franklin WA, Dempsey EC, Murphy JR, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 2001;18:1385-91.
42. Yokose T, Ito Y, Ochiai A. High prevalence of atypical adenomatous hyperplasia of the lunginautopsy specimens from elderly patients with malignant neoplasms. Lung Cancer 2000;2:125-30.
43. Veronesi G, Szabo E, Decensi A, Guerrieri-Gonzaga A, Bellomi M, Radice D, et al. Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. Cancer Prev Res 2011;1:34-42.
44. Heuvelmans MA, Oudkerk M, de Bock GH, de Koning HJ, Xie X, van Ooijen PM, et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 2013;7:1836-45.
45. Coldren CD, Miller YE. Progressive endobronchial premalignancy: marked by original CIN. Am J Respir Crit Care Med 2011;8: 869-70.
46. Breuer RH, Pasic A, Smit EF, van Vliet E, Vonk Noordegraaf A, Risse EJ, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 2005;11(2 Pt 1):537-43.
47. Jeremy George P, Banerjee AK, Read CA, O'Sullivan C, Falzon M, Pezzella F, et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 2007;1:43-50.
48. Lam S, leRiche JC, McWilliams A, Macaulay C, Dyachkova Y, Szabo E, et al. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res 2004;19:6502-11.
49. van den Berg RM, Teertstra HJ, van Zandwijk N, van Tinteren H, Visser C, Pasic A, et al. CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone. Lung Cancer 2008;1:57-61.
50. Raad RA, Suh J, Harari S, Naidich DP, Shiau M, Ko JP. Nodule characterization: subsolid nodules. Radiol Clin North Am 2014;1:47-67.
51. Lee KH, Goo JM, Park SJ, Wi JY, Chung DH, Go H, et al. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. J Thorac Onc 2014;1:74-82.
52. Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Cavalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Comm 2014;5:4006.
53. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Int Med 2014;2:269-74.
54. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Int Med 2012;11: 776-84.
55. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;2:555-62.
56. Infante M, Berghmans T, Heuvelmans MA, Hillerdal G, Oudkerk M. Slow-growing lung cancer as an emerging entity: from screening to clinical management. Eur Respir J 2013;6:1706-22.